Intratumoral stem-like CD8+ T cells (TSL) are necessary for immunotherapeutic efficacy. Yet, tumors are rich in signals driving terminal differentiation of TSL cells into exhausted T cells. Using the “KP-NINJA” lung tumor model, we determined that tumor-specific TSL cells terminally differentiate in tumors, but that they are maintained by a reservoir of TSL cells from the tumor-draining lymph node (dLN). By tracing clones of tumor-specific CD8+ T cells using single-cell RNA/TCRseq, we found that dLN TSL cells were the developmental precursors of the more differentiated intratumoral T cell populations. Moreover, dLN TSL cells were developmentally stable over the disease course and blocking egress from dLNs resulted in a decrease in intratumoral TSL cells. Thus, we propose that the dLN reservoir protects the overall tumor-specific T cell population from terminal differentiation, allowing for prolonged responses under conditions of chronic antigen exposure. Future immunotherapeutic strategies could leverage this reservoir for anti-tumor effects.
Connolly, Kelli and Kuchroo, Manik and Kuchroo, Manik and Venkat, Aarthi and Khatun, Achia and Fitzgerald, Brittany and Damo, Martina and Kasmani, Moujtaba Y. and Cui, Can and Monroy, Isabel and Hutchins, Amanda and Cui, Weiguo and Krishnaswamy, Smita and Krishnaswamy, Smita and Krishnaswamy, Smita and Joshi, Nikhil S., A Reservoir of Stem-Like CD8 T Cells in the Tumor-Draining Lymph Node Maintains the Ongoing Anti-Tumor Immune Response. Available at SSRN: https://ssrn.com/abstract=3640763 or http://dx.doi.org/10.2139/ssrn.3640763
This version of the paper has not been formally peer reviewed.
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
20
PAPERS
9,210
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.